Ismail has over seven years of life sciences value communication, access and pricing strategy experience in U.S. and key global markets. In his work, Ismail leverages 10+ years of medical research experience to address challenges for pharmaceutical and biotech industry clients, across a broad spectrum of therapeutic areas including oncology, rare diseases, and cell and gene therapies. Ismail has a PhD in Genetics & Dev. Biology from UT Southwestern Medical Center and a BSc in Molecular Biology & Genetics from Bilkent University.